Literature DB >> 11685353

Gemcitabine-associated diffuse alveolar hemorrhage.

P L Carron, L Cousin, T Caps, E Belle, D Pernet, A Neidhardt, G Capellier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11685353     DOI： 10.1007/s001340101037

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Diffuse alveolar damage in a patient treated with gemcitabine.

Authors:  A Marruchella; G Fiorenzano; A Merizzi; G Rossi; P L Chiodera
Journal:  Eur Respir J       Date:  1998-02       Impact factor: 16.671

2.  Fatal pulmonary toxicity resulting from treatment with gemcitabine.

Authors:  N Pavlakis; D R Bell; M J Millward; J A Levi
Journal:  Cancer       Date:  1997-07-15       Impact factor: 6.860

Review 3.  Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management.

Authors:  R J Green; S J Ruoss; S A Kraft; S R Duncan; G J Berry; T A Raffin
Journal:  Chest       Date:  1996-11       Impact factor: 9.410

Review 4.  Gemcitabine--a safety review.

Authors:  M S Aapro; C Martin; S Hatty
Journal:  Anticancer Drugs       Date:  1998-03       Impact factor: 2.248
  4 in total
  2 in total

1.  Increased risk of high-grade hemorrhage in cancer patients treated with gemcitabine: a meta-analysis of 20 randomized controlled trials.

Authors:  Yi Hu; Jingliang Wang; Haitao Tao; Baishou Wu; Jin Sun; Yao Cheng; Weiwei Dong; Ruixin Li
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

2.  Diffuse Alveolar Hemorrhage Induced by Irinotecan for a Patient with Metastatic Thymic Carcinoma: A Case Report and Literature Review.

Authors:  Sung-Ho Kim; Seigo Minami; Yoshitaka Ogata; Suguru Yamamoto; Kiyoshi Komuta
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.